These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36792080)

  • 1. [Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors].
    Xie G; Cheng J; Zhang J
    Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):46-51. PubMed ID: 36792080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
    Wu K; Li X; Gu H; Yang Q; Liu Y; Wang L
    Int J Biol Sci; 2019; 15(12):2576-2583. PubMed ID: 31754330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.
    Wu J; Li L; Wu S; Xu B
    Cancer Biol Med; 2020 Aug; 17(3):528-542. PubMed ID: 32944388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.
    Duan SL; Jiang Y; Li GQ; Fu W; Song Z; Li LN; Li J
    PeerJ; 2024; 12():e16757. PubMed ID: 38223763
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
    Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Research Advance in CKLF-like MARVEL Transmembrane Domain Containing Member Family (Review).
    Lu J; Wu QQ; Zhou YB; Zhang KH; Pang BX; Li L; Sun N; Wang HS; Zhang S; Li WJ; Zheng W; Liu W
    Asian Pac J Cancer Prev; 2016; 17(6):2741-4. PubMed ID: 27356683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
    Duan HJ; Li XY; Liu C; Deng XL
    Chin Med J (Engl); 2020 Apr; 133(8):951-958. PubMed ID: 32195671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible effects of chemokine-like factor-like MARVEL transmembrane domain-containing family on antiphospholipid syndrome.
    Ge YY; Duan HJ; Deng XL
    Chin Med J (Engl); 2021 Apr; 134(14):1661-1668. PubMed ID: 33813507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
    Chui NN; Cheu JW; Yuen VW; Chiu DK; Goh CC; Lee D; Zhang MS; Ng IO; Wong CC
    Hepatol Commun; 2022 Jan; 6(1):178-193. PubMed ID: 34558800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of CMTM family in pan-cancer and preliminary exploration of CMTM6 in bladder cancer.
    Xu Y; Li Q; Lin H
    Cell Signal; 2024 Mar; 115():111012. PubMed ID: 38113979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Advances in Chemokine-like Factor Super Family Member 8.
    Gao DH; Hu H; Fang ZW; Huo F; Wang HR; Xu KX; Wang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):746-749. PubMed ID: 28065246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.
    Delic S; Thuy A; Schulze M; Proescholdt MA; Dietrich P; Bosserhoff AK; Riemenschneider MJ
    Genes Chromosomes Cancer; 2015 Jul; 54(7):433-43. PubMed ID: 25931111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3.
    Hu FZ; Sheng ZZ; Qin CP; Xu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):360-3. PubMed ID: 27469927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
    Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.
    Zhang T; Yu H; Dai X; Zhang X
    Front Immunol; 2022; 13():971428. PubMed ID: 35958549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma: Latest Advances.
    Li M; Luo F; Tian X; Yin S; Zhou L; Zheng S
    Front Oncol; 2020; 10():595973. PubMed ID: 33282744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) expression in gastric cancer.
    Nishi M; Shimada M; Yoshikawa K; Higashijima J; Tokunaga T; Kashihara H; Takasu C; Eto S; Yoshimoto T
    J Med Invest; 2021; 68(3.4):362-367. PubMed ID: 34759159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and prognostic significance of CMTM6/PD-L1 in oncology.
    Yaseen MM; Abuharfeil NM; Darmani H
    Clin Transl Oncol; 2022 Aug; 24(8):1478-1491. PubMed ID: 35278198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMTM6, a potential immunotherapy target.
    Liang J; Li S; Li W; Rao W; Xu S; Meng H; Zhu F; Zhai D; Cui M; Xu D; Cai J; Zhang B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):47-56. PubMed ID: 34783871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
    Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
    Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.